Our Company
Omne Possibile brings together the key disciplines of XNA development: chemical synthesis, genetics,
directed evolution of enzymes and genomes, automated design of molecules and bioproduction pathways.
Omne Possibile has launched two R&D innovation labs in Leuven, Belgium, and Basel, Switzerland,
to accelerate product development and commercialization with a world-class team.
BASEL, SWITZERLAND
- Design & construction of metabolic pathways
- Synthetic genomes & replicons
- Enzymatic, microbial & cellular fluidics
LEUVEN, BELGIUM
- Nucleoside, nucleotide & nucleic acids chemistry
- XNA design & synthesis
- XNA enzymology & amplification
Founders
Philippe Marlière
Head of Genetics
Piet Herdewijn
Head of Chemistry
Sven Panke
ETH Zürich
Patrice Garnier
Entrepreneur
Alexandre Mourandian
Eurekare, Luxembourg
Advisors
Gerard Le Fur
Former CEO of Sanofi-Aventis
Steven Benner
FfAME, Florida
John Chaput
University of California, Irvine
Ada Yonath
Weizmann Institute, Rehovot Nobel Laureate, Chemistry, 2009
Janine Cossy
ESPCI, Paris
Jason Chin
MRC Cambridge
Serge Ratton
Former CSO of Rhodia
Jean-Marie Lehn
University of Strasbourg
Nobel Laureate, Chemistry, 1987